Intensive lifestyle management or earlier-generation medications

Intervention

1 paper studies it2 findings

Across all fields, 1 paper: none in people yet

In silico1

Outcomes

Major complications

downin silico1

1 study

Intensive lifestyle management or earlier-generation medications prevent major complications in silico (17–23% of major complications prevented).
“expanded access to intensive lifestyle management or earlier-generation medications would prevent 3% of deaths and 17-23% of major complications”
In silicoU.S. adults with obesity; expanded access compared with current limited treatment access10 years
Model projects preventable deaths under limited US obesity care
Diabetes, obesity, and cardiometabolic CAREJun 7, 2026

Mortality

downin silico1−3% deaths prevented

1 study

Intensive lifestyle management or earlier-generation medications decrease mortality in silico (3% of deaths prevented).
“expanded access to intensive lifestyle management or earlier-generation medications would prevent 3% of deaths and 17-23% of major complications”
In silicoU.S. adults with obesity; expanded access compared with current limited treatment access10 years
Model projects preventable deaths under limited US obesity care
Diabetes, obesity, and cardiometabolic CAREJun 7, 2026

Latest

1 paper in 12 months

Diabetes, Obesity, and Cardiometabolic CAREOct 18

Model projects preventable deaths under limited US obesity care

For 107.6 million US adults with obesity, the simulation estimated 5.3 million preventable deaths over 10 years if treatment was forgone.For 107.6 million US adults with obesity, the simulation estimated 5.3 million preventable deaths over 10 years if treatment was forgone.

Computational studyObesity

Paper

Intensive lifestyle management or earlier-generation medications

Outcomes

Latest

Model projects preventable deaths under limited US obesity care

Related